DK344080A - Fremgangsmaade til fremstilling af betalactamantibiotika - Google Patents

Fremgangsmaade til fremstilling af betalactamantibiotika

Info

Publication number
DK344080A
DK344080A DK344080A DK344080A DK344080A DK 344080 A DK344080 A DK 344080A DK 344080 A DK344080 A DK 344080A DK 344080 A DK344080 A DK 344080A DK 344080 A DK344080 A DK 344080A
Authority
DK
Denmark
Prior art keywords
actamibiotics
payment
procedure
preparation
payment actamibiotics
Prior art date
Application number
DK344080A
Other languages
Danish (da)
English (en)
Inventor
D F Carbett
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK344080A publication Critical patent/DK344080A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK344080A 1979-08-10 1980-08-08 Fremgangsmaade til fremstilling af betalactamantibiotika DK344080A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7927901 1979-08-10
GB8012724 1980-04-17

Publications (1)

Publication Number Publication Date
DK344080A true DK344080A (da) 1981-02-11

Family

ID=26272503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK344080A DK344080A (da) 1979-08-10 1980-08-08 Fremgangsmaade til fremstilling af betalactamantibiotika

Country Status (12)

Country Link
US (1) US4473578A (de)
EP (2) EP0024832B1 (de)
AU (1) AU6119680A (de)
CA (1) CA1175841A (de)
DE (1) DE3070269D1 (de)
DK (1) DK344080A (de)
ES (2) ES8106308A1 (de)
FI (1) FI802446A (de)
GR (1) GR69935B (de)
IL (1) IL60758A0 (de)
NO (1) NO802377L (de)
NZ (1) NZ194584A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072121A1 (de) * 1981-08-08 1983-02-16 Beecham Group Plc Beta-Lactam Antibiotika
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0079167A1 (de) * 1981-11-09 1983-05-18 Beecham Group Plc Carbapenem-Verbindung, Herstellung und Verwendung
EP0079244B1 (de) * 1981-11-10 1986-12-30 Shionogi & Co., Ltd. Pluracidomycin B,C und D und deren Analoge, ihre Herstellung und ein dabei verwendbarer Mikroorganismus
US4556517A (en) * 1981-12-29 1985-12-03 Shionogi & Co., Ltd. Carbapenem derivatives
ATE28648T1 (de) * 1982-03-26 1987-08-15 Hoechst Uk Ltd 7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-derivate
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
ATE112778T1 (de) * 1982-11-29 1994-10-15 Schering Corp Verfahren zur herstellung von penem-verbindungen.
EP0137403A3 (de) * 1983-09-28 1987-04-15 Takeda Chemical Industries, Ltd. Carbapenem-Verbindungen, ihre Herstellung und Verwendung
US4698339A (en) * 1983-09-28 1987-10-06 Takeda Chemical Industries, Ltd. Carbapenems, their production and use
ZA848416B (en) * 1983-11-10 1986-06-25 Dow Chemical Co Fluorophenoxy compounds,herbicidal compositions and methods
US4717728A (en) * 1983-11-21 1988-01-05 Merck & Co., Inc. Cyclic amidinyl and cyclic guanidinyl thio carbapenems

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531141A (en) * 1976-08-17 1978-11-01 Beecham Group Ltd Beta-lactam antibiotics
NL7802826A (nl) * 1977-04-08 1978-10-10 Merck & Co Inc Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
US4235917A (en) * 1977-05-05 1980-11-25 Merck & Co., Inc. N-Alkyl-N-acyl derivatives of thienamycin
EP0001567B1 (de) * 1977-10-13 1981-12-02 Sanraku-Ocean Co., Ltd. Thienamycin verwandte Antibiotika PS-6 und PS-7, Verfahren zu ihrer Herstellung sowie sie enthaltende Zusammensetzungen
US4347367A (en) * 1977-10-19 1982-08-31 Merck & Co., Inc. 3-Substituted-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
US4347368A (en) * 1977-10-19 1982-08-31 Merck & Co., Inc. 3-Substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
EP0003740B1 (de) * 1978-01-19 1982-01-27 Beecham Group Plc Beta-Lactamantibiotika, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0004132A1 (de) * 1978-03-04 1979-09-19 Beecham Group Plc Beta-Lactamester Antibiotika, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
US4203902A (en) * 1978-04-21 1980-05-20 Merck & Co., Inc. Process for preparing 6- and 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0005349A1 (de) * 1978-05-06 1979-11-14 Beecham Group Plc Alkylcarbapeneme, ihre Herstellung, pharmazeutische Zubereitungen und Zwischenprodukte
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
DE2963580D1 (en) * 1978-08-02 1982-10-21 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
EP0008888B1 (de) * 1978-08-23 1983-09-21 Beecham Group Plc Antibakterielle Beta-Lactam-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2961882D1 (en) * 1978-08-25 1982-03-04 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
DE2966446D1 (en) * 1978-09-09 1984-01-05 Beecham Group Plc Beta-lactam compounds, their preparation and use
DE2965394D1 (en) * 1978-11-01 1983-06-16 Sanraku Ocean Co Process for producing antibiotic beta-lactam compounds
EP0017992A1 (de) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituierte-6-substituierte-1-Carbadethiapen-2-em-3-carbonsäuren, Verfahren zu ihrer Herstellung, sie enthaltende antibiotische pharmazeutische Zusammensetzungen und Verfahren zur Herstellung von Zwischenprodukten
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin

Also Published As

Publication number Publication date
ES494136A0 (es) 1981-08-01
US4473578A (en) 1984-09-25
FI802446A (fi) 1981-02-11
NO802377L (no) 1981-02-11
NZ194584A (en) 1983-05-31
CA1175841A (en) 1984-10-09
EP0024832A1 (de) 1981-03-11
EP0024832B1 (de) 1985-03-13
ES8106308A1 (es) 1981-08-01
EP0055990A1 (de) 1982-07-14
ES8202010A1 (es) 1982-01-16
EP0055990B1 (de) 1986-06-11
ES499856A0 (es) 1982-01-16
GR69935B (de) 1982-07-21
AU6119680A (en) 1981-02-12
IL60758A0 (en) 1980-10-26
DE3070269D1 (en) 1985-04-18

Similar Documents

Publication Publication Date Title
DK29681A (da) Fremgangsmaade til fremstilling af immunogammaglobulin
DK546080A (da) Fremgangsmaade til fremstilling af galactosaccharosederivater
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK311580A (da) Fremgangsmaade til fremstilling af oxoalkylxanthiner
DK6180A (da) Fremgangsmaade til fremstilling af 2-pennemforbindelser
DK365280A (da) Fremgangsmaade til fremstilling af ftaliminderivater
DK307480A (da) Fremgangsmaade til fremstilling af neopentylamin
DK274580A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK344080A (da) Fremgangsmaade til fremstilling af betalactamantibiotika
DK149623C (da) Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider
DK153791C (da) Fremgangsmaade til fremstilling af 7-hydroxycumaraner
DK552180A (da) Fremgangsmaade til fremstilling af tetrapeptidsemikarbazidderivater
DK394080A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK481280A (da) Fremgangsmaade til fremstilling af piperidylbenzimidazolinonderivater
DK262180A (da) Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater
DK187980A (da) Fremgangsmaade til fremstilling af benzimidazolderivater
DK274680A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK222880A (da) Fremgangsmaade til fremstilling af anthracyclinonderivater
DK304080A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK69680A (da) Fremgangsmaade til fremstilling af diorganomagnesiumforbindelser
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK318280A (da) Fremgangsmaade til fremstilling af naphthyridinderivater
DK546180A (da) Fremgangsmaade til fremstilling af triazepinderivater
DK156427C (da) Fremgangsmaade til fremstilling af n-alkylarylaminer